Prof David Christie

Clinical interests in urological (including prostate) cancers, and skin cancers plus benign conditions suitable for radiation therapy.

Professor David Christie is based on the Gold Coast and attends GenesisCare treatment centres at Tugun and Southport. He also attends clinics in Northern NSW (Ballina).

David qualified in Medicine from New Zealand’s University of Otago in 1987 and completed Radiation Oncology training in Sydney in 1995, at which time he moved to Queensland and commenced full-time practice. David has over 30 years’ experience in treating many cancer types that require radiation therapy.

He has research and teaching roles with the University of New England as well as Bond and Griffith Universities. Special clinical interests include urological cancer (including prostate SABR), skin cancer (including wide field radiotherapy), benign diseases (including dupuytren’s disease), lymphoma and patients eligible for clinical trials.

In addition to his clinical and academic roles, Professor Christie participates in multidisciplinary team (MDT) meetings across Northern NSW and the Gold Coast, working collaboratively with specialist colleagues to support comprehensive, coordinated patient care.

He is an active contributor to several clinical trial organisations including TROG and has published over 200 publications which are accessible online.

Professional memberships

• Royal Australian and New Zealand College of Radiologists (RANZCR)
• Trans-Tasman Radiation Oncology Group (TROG)
• Bond University
• Griffith University
• University of New England

• Urological cancer
• Skin cancer
• Lymphoma
• Metastatic cancer
• Dupuytren's disease
• Ledderhose disease
• Osteoarthritis
• Keloid scars
• Soft tissue sarcoma

Treatment techniques

• External beam radiation therapy (EBRT)
• Volumetric modulated arc therapy (VMAT)
• Stereotactic radiotherapy (SBRT/SABR)
• Radiation therapy for benign conditions
• Palliative radiation therapy
• Hormone therapy